Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07950319

Exploring the Use of Fecal Microbiota Transplantation in Treating Diabetes-Related Constipation

Conditions: Functional Constipation (FC), Fecal Microbiota Transplantation, Type 2 Diabetes Mellitus (T2DM)

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 30
Sponsor: Shanghai 10th People's Hospital

Location: Shanghai Tenth People's Hospital Shanghai Shanghai Municipality

Summary

This study aims to retrospectively evaluate the clinical effectiveness and safety of fecal microbiota transplantation (FMT) in treating patients with functional constipation (FC) who also have type 2 diabetes mellitus (T2DM). It analyzes changes in bowel function, glucose metabolism indicators, and gut microbiota structure before and after FMT, and further explores the relationship between donor-related microbiota remodeling, predicted microbial metabolic functions, and clinical outcomes.

Eligibility Criteria

Inclusion Criteria: 1. Clearly diagnosed with functional constipation. 2. Clearly diagnosed with type 2 diabetes. 3. Received FMT treatment between January 2020 and December 2024. 4. Have clinical data before and after FMT treatment. 5. Have stool samples before and after FMT treatment for gut microbiota analysis. Exclusion Criteria: 1. Combined gastrointestinal malignancies. 2. History of gastrointestinal surgery. 3. Presence of megacolon. 4. History of broad-spectrum antibiotic use.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07950319). StuddyBuddy aggregates publicly available trial information.